Cargando…
Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines
Melanoma is an aggressive cancer type with a high mortality rate and an elevated resistance to conventional treatment. Recently, promising new tools for anti-melanoma targeted therapy have emerged including inhibitors directed against frequently overexpressed receptors of growth factors implicated i...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915070/ https://www.ncbi.nlm.nih.gov/pubmed/29719603 http://dx.doi.org/10.18632/oncotarget.24810 |